303 related articles for article (PubMed ID: 6373932)
1. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
Jaffe CL; Bennett E; Grimaldi G; McMahon-Pratt D
J Immunol; 1984 Jul; 133(1):440-7. PubMed ID: 6373932
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
Jaffe CL; McMahon-Pratt D
J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
[TBL] [Abstract][Full Text] [Related]
3. Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
Pratt DM; Bennett E; Grimaldi G; Jaffe CL
J Immunol; 1985 Mar; 134(3):1935-40. PubMed ID: 2578524
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
Pan AA; McMahon-Pratt D
J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
[TBL] [Abstract][Full Text] [Related]
5. Identification of highly specific and cross-reactive antigens of Leishmania species by antibodies from Leishmania (Leishmania) chagasi naturally infected dogs.
Vale AM; Fujiwara RT; da Silva Neto AF; Miret JA; Alvarez DC; da Silva JC; Campos-Neto A; Reed S; Mayrink W; Nascimento E
Zoonoses Public Health; 2009 Feb; 56(1):41-8. PubMed ID: 18990196
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
7. Species and stage specificity of Leishmania donovani antigens.
White AC; Hanham C
J Parasitol; 1991 Feb; 77(1):142-50. PubMed ID: 1704058
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
Jaffe CL; Rachamim N; Sarfstein R
J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
[TBL] [Abstract][Full Text] [Related]
9. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
Pan AA; McMahon-Pratt D
J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
[TBL] [Abstract][Full Text] [Related]
10. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
[TBL] [Abstract][Full Text] [Related]
11. [The determination of the species specificity of Leishmania antibodies in different groups of human sera].
Giboda M; Goncharov DB; Saf'ianova VM; Gracheva LI; Ditrich O
Med Parazitol (Mosk); 1991; (3):29-32. PubMed ID: 1770880
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies that react with Leishmania (Viannia) naiffi.
Hanham CA; Shaw JJ; Lainson R
J Parasitol; 1991 Oct; 77(5):680-7. PubMed ID: 1919913
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
14. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
Karp CL; Turco SJ; Sacks DL
J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
[TBL] [Abstract][Full Text] [Related]
15. Species-specific antibodies to Leishmania tropica (minor) recognize somatic antigens and exometabolites.
Jaffe CL; Sarfstein R
J Immunol; 1987 Aug; 139(4):1310-9. PubMed ID: 3302043
[TBL] [Abstract][Full Text] [Related]
16. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
Sinha R; Arora SK; Datta U; Sehgal S
Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
[TBL] [Abstract][Full Text] [Related]
17. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
18. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar.
Salotra P; Raina A; Negi NS
Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370
[TBL] [Abstract][Full Text] [Related]
19. [Application of monoclonal antibodies against Leishmania donovani, II. Detection of circulating antigen in sera of visceral leishmaniasis before and after treatment].
Qu JQ; Xu YX; Bao YF; Yang YT; Wang JY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(1):21-3. PubMed ID: 2065447
[TBL] [Abstract][Full Text] [Related]
20. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
Kohanteb J; Rezai HR; Ardehali S
J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
